↓ Skip to main content

Study protocol of REGOSARC trial: activity and safety of regorafenib in advanced soft tissue sarcoma: a multinational, randomized, placebo-controlled, phase II trial

Overview of attention for article published in BMC Cancer, March 2015
Altmetric Badge

Citations

dimensions_citation
22 Dimensions

Readers on

mendeley
47 Mendeley